Meta-Analysis of the Usefulness of Beta-Blockers to Reduce the Risk of Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease Without Prior Myocardial Infarction or Left Ventricular Dysfunction-Reference-Cited by-同舟云学术

Meta-Analysis of the Usefulness of Beta-Blockers to Reduce the Risk of Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease Without Prior Myocardial Infarction or Left Ventricular Dysfunction

Published:2021-11 Issue: Volume:158 Page:23-29
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Arero Amanuel Godana,Vasheghani-Farahani Ali,Soltani Danesh

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference52 articles.

1. Contributions of the Framingham heart study to the epidemiology of coronary heart disease;Chen;JAMA Cardiol,2016

2. Epidemiological studies of CHD and the evolution of preventive cardiology;Wong;Nat Rev Cardiol,2014

3. The myth of ‘stable'coronary artery disease;Fox;Nat Rev Cardiol,2020

4. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC);Knuuti;Eur Heart J,2020

5. Three generations of β-blockers: history, class differences and clinical applicability;do Vale;Curr Hypertens Rev,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the gaps: Hypertension control beyond the cascade of care framework;The Journal of Clinical Hypertension;2024-06-09

2. Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?;Korean Circulation Journal;2024

3. Predictors of Premature Mortality Following Coronary Artery Bypass Grafting: An Iranian Single-Centre Study;Healthcare;2023-12-23

4. Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease;Journal of the American College of Cardiology;2023-06

5. AKT-mTOR signaling-mediated rescue of PRKAG2 R302Q mutant-induced familial hypertrophic cardiomyopathy by treatment with β-adrenergic receptor (β-AR) blocker metoprolol;Cardiovascular Diagnosis and Therapy;2022-06